Next Article in Journal
Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma
Next Article in Special Issue
Sunitinib-Containing Carborane Pharmacophore with the Ability to Inhibit Tyrosine Kinases Receptors FLT3, KIT and PDGFR-β, Exhibits Powerful In Vivo Anti-Glioblastoma Activity
Previous Article in Journal
Ramucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial
Previous Article in Special Issue
The DYRK Family of Kinases in Cancer: Molecular Functions and Therapeutic Opportunities
 
 
Article

Article Versions Notes

Cancers 2020, 12(10), 2986; https://doi.org/10.3390/cancers12102986
Action Date Notes Link
article pdf uploaded. 15 October 2020 13:47 CEST Version of Record https://www.mdpi.com/2072-6694/12/10/2986/pdf-vor
article supplementary file uploaded. 15 October 2020 13:47 CEST - https://www.mdpi.com/2072-6694/12/10/2986#supplementary
article xml file uploaded 16 October 2020 05:15 CEST Original file -
article xml uploaded. 16 October 2020 05:15 CEST Update -
article pdf uploaded. 16 October 2020 05:15 CEST Updated version of record https://www.mdpi.com/2072-6694/12/10/2986/pdf-vor
article html file updated 16 October 2020 05:17 CEST Original file -
article xml file uploaded 20 October 2020 12:49 CEST Update -
article xml uploaded. 20 October 2020 12:49 CEST Update https://www.mdpi.com/2072-6694/12/10/2986/xml
article pdf uploaded. 20 October 2020 12:49 CEST Updated version of record https://www.mdpi.com/2072-6694/12/10/2986/pdf
article html file updated 20 October 2020 12:51 CEST Update -
article html file updated 22 July 2022 21:09 CEST Update https://www.mdpi.com/2072-6694/12/10/2986/html
Back to TopTop